Skip to main content
. 2020 Jul 28;100(14):5819. doi: 10.2340/00015555-3569

Table I.

Responder characteristics of geriatric psoriasis patients (≥65 years old) compared with patients < 65 years old

< 65 years old (n = 536) ≥65 years old (n = 414) p-value
Sex, n (%) < 0.001
 Male 247 (46.2) 246 (59.6)
 Female 288 (53.8) 167 (40.4)
Age, years, median (range) 56 (7–64) 71 (65–95) NA
 Mean ± SD 52.4 ± 11.4 72.4 ± 5.9
Age at onset, n (%) NA
 Early onseta 459 (85.6) 305 (73.7)
 Late onsetb 74 (13.8) 108 (26.1)
 Unknown 2 (0.4) 0 (0.0)
Family history of psoriasis, n (%) 0.719
 Positivec 333 (62.2) 266 (64.6)
 Negative 118 (22.1) 88 (21.4)
 Unknown 84 (15.7) 58 (14.1)
Medical history, n (%)
 Overweight (BMI > 25) 285 (53.7) 250 (62.3) 0.008
 Hypertension 108 (20.5) 197 (49.0) <0.001
 Hypercholesterolaemia 68 (12.9) 149 (37.3) <0.001
 Myocardial infarction 10 (1.9) 35 (8.8) <0.001
 Heart failure 21 (4.0) 66 (16.6) <0.001
 Cerebral vascular accident 9 (1.7) 22 (5.5) 0.002
 Diabetes mellitus 25 (4.7) 64 (15.9) <0.001
 Cancerd 44 (8.3) 94 (23.2) <0.001
 Depression 99 (18.9) 69 (17.3) 0.530
Use of comedicatione n (%) 236 (44.7) 306 (75.6) < 0.001

Values might not add up due to missing values.

a

Defined as onset of symptoms before and

b

after the age of 40 years (14).

c

Including all family members affected by psoriasis. Separate analyses were done only including first-degree family members; 233 (43.6%) patients < 65 years old reported 1 or more affected first-degree family members, compared with 206 (50.0%) patients ≥ 65 years old (p = 0.142).

d

Excluding non-melanoma skin cancer (n = 25). In uncertain cases (e.g. 30 patients reported “skin cancer”), patients were included in the analysis.

e

Other than psoriasis medication.

NA: not applicable, since the categorization of patients in separate age groups automatically leads to differences in age-related variables; BMI: body mass index; SD: standard deviation.